Similar articles

• In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.

  Akhter SA, Eckhart AD, Rockman HA, Shotwell K, Lefkowitz RJ, Koch WJ. Akhter SA, et al. Circulation. 1999 Aug 10;100(6):648-53. doi: 10.1161/01.cir.100.6.648. Circulation. 1999. PMID: 10441103
• The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes.

  Steinberg SF. Steinberg SF. Circ Res. 1999 Nov 26;85(11):1101-11. doi: 10.1161/01.res.85.11.1101. Circ Res. 1999. PMID: 10571542 Review. No abstract available.
• The beta-adrenergic signaling pathway in the heart.

  Homcy CJ. Homcy CJ. Hosp Pract (Off Ed). 1991 May 15;26(5):43-50. doi: 10.1080/21548331.1991.11704172. Hosp Pract (Off Ed). 1991. PMID: 1851499
• Beta-adrenergic pathway in healthy and hypertrophied hearts.

  Barros Rde A, Okoshi MP, Cicogna AC. Barros Rde A, et al. Arq Bras Cardiol. 1999 May;72(5):641-56. doi: 10.1590/s0066-782x1999000500012. Arq Bras Cardiol. 1999. PMID: 10668235 Review. English, Portuguese. No abstract available.
• Recent advances in cardiac beta(2)-adrenergic signal transduction.

  Xiao RP, Cheng H, Zhou YY, Kuschel M, Lakatta EG. Xiao RP, et al. Circ Res. 1999 Nov 26;85(11):1092-100. doi: 10.1161/01.res.85.11.1092. Circ Res. 1999. PMID: 10571541 Review.